Prof. Dr. med. habil. Uwe Paasch

Prof. Dr. med. habil. Uwe Paasch

Prof. Dr. med. habil. Uwe Paasch
FA Haut- und Geschlechtskrankheiten, Venerologie

Zusatzqualifikationen:
Allergologie, Dermatohistopathologie, Andrologie
eigene Hautarzt-Praxis in Gotha

Curriculum Vitae

Leitender Arzt, Wissenschaftler, Dermatopathologe,
klinischer Androloge und Akademiker der Europäischen Akademie für Andrologie,
Klinik für Dermatologie und Zentrum der Europäischen Akademie für Andrologie, Universität Leipzig
Ärztlicher Leiter Praxis Prof. Uwe Paasch, Privatpraxis und Tiliaderm Laser Research Institute

 

Februar 1985 – Mai 1985 Tätigkeit in der Röntgenforschung
Mai 1985 – April 1988 Armee – Feldwebel-Abschluss obligatorisch
Mai 1988 – August 1989 Praktisches Jahr in der Krankenpflege - Krankenhaus Eilenburg
Oktober 1995 Allergopharma Hamburg, Forschung in der Allergie
November 1995 – April 1997 Junior House Officer, Universität Leipzig, Klinik für Dermatologie
Mai 1997 – März 2001 Praktikant, Universität Leipzig, Klinik für Dermatologie
April 2001 – Mai 2002 Berater und Wissenschaftler, Universität Leipzig, Klinik für Dermatologie
Juni 2002 – Berater, Wissenschaftler und Oberarzt an der Hautklinik der Universität Leipzig
Dezember 2007 Professor für Dermatologie

 

 

Andere Erfahrungen und professionelle Mitgliedschaften

Deutsche Gesellschaft der Ärzte, Deutsche Gesellschaft für Dermatologie (DDG), Deutsche Dermatologische Akademie (DDA, Speaker Laser), Deutsche Gesellschaft für Dermatologische Chirurgie (DGDC, Speaker Laser), Deutsche Dermatologische Lasergesellschaft (ehemaliger Präsident, Vorstandsmitglied), Europäische Gesellschaft für Laser- und energiebasierte Geräte (ehemaliger Vizepräsident), Deutsche Gesellschaft für Andrologie (ehemaliger Schatzmeister), Europäische Akademie für Andrologie (Akademiker)

Ehrungen

2004 Research Excellence Award der Cleveland Clinic Foundation
2006 Forschungspreis der Deutschen Dermatologischen Gesellschaft
2014 DDL Laser Innovation Award
2017 BVDD-Innovationspreis Dermatologie

Veröffentlichungen (Auswahl)

Ausgewählte, kürzlich von Experten begutachtete Veröffentlichungen im Laserbereich der letzten 5 Jahre.
(Ausgewählt aus ~ 265 peer-reviewten Veröffentlichungen, gelistet im Web of Science, h-Index: 36)

1 Engel KM, Grunewald S, Schiller J, Paasch U. Automated semen analysis by SQA Vision((R)) versus the manual approach-A prospective double-blind study. Andrologia. 2019; 51: e13149.

2 Karmisholt KE, Banzhaf CA, Glud M et al. Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls. Br. J. Dermatol. 2018.

3 Karmisholt KE, Haerskjold A, Karlsmark T et al. Early laser intervention to reduce scar formation - a systematic review. J. Eur. Acad. Dermatol. Venereol. 2018.

4 Karmisholt KE, Wenande E, Thaysen-Petersen D et al. Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels. Lasers Surg. Med. 2018; 50: 28-36.

5 Uhrlass S, Schroedl W, Mehlhorn C et al. Molekulare Epidemiologie von Trichophyton quinckeanum - ein zoophiler Dermatophyt im Aufwind. J. Dtsch. Dermatol. Ges. 2018; 16: 21-33.

6 Uhrlass S, Schroedl W, Mehlhorn C et al. Molecular epidemiology of Trichophyton quinckeanum - a zoophilic dermatophyte on the rise. J. Dtsch. Dermatol. Ges. 2018; 16: 21-32.

7 Haak CS, Hannibal J, Paasch U et al. Laser-induced thermal coagulation enhances skin uptake of topically applied compounds. Lasers Surg. Med. 2017.

8 Karmisholt KE, Wenande E, Thaysen-Petersen D et al. Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels. Lasers Surg. Med. 2017.

9 Nenoff P, Manos A, Ehrhard I et al. [Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads]. Hautarzt. 2017; 68: 136-148.

10 Paasch U, Schwandt A, Seeber N et al. Neue Laser und Strahlquellen - alte und neue Risiken? J. Dtsch. Dermatol Ges. 2017; 15: 487-497.

11 Paasch U, Schwandt A, Seeber N et al. New lasers and light sources - old and new risks? J. Dtsch. Dermatol Ges. 2017; 15: 487-496.

12 Seitz AT, Paasch U, Paasch H et al. Erythematous facial papules and pustules in an 8-year-old girl. J. Dtsch. Dermatol Ges. 2017; 15: 98-100.

13 Seitz AT, Paasch U, Paasch H et al. Erythematose Papeln und Pusteln im Gesicht eines 8-jahrigen Madchens. J. Dtsch. Dermatol Ges. 2017; 15: 101-103.

14 Banzhaf CA, Wind BS, Mogensen M et al. Spatiotemporal closure of fractional laser-ablated channels imaged by optical coherence tomography and reflectance confocal microscopy. Lasers Surg. Med. 2016; 48: 157-165.

15 Haedersdal M, Erlendsson AM, Paasch U, Anderson RR. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status. J. Am. Acad. Dermatol. 2016.

16 Haedersdal M, Erlendsson AM, Paasch U, Anderson RR. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status. J. Am. Acad. Dermatol. 2016; 74: 981-1004.

17 Jorgensen N, Joensen UN, Toppari J et al. Compensated reduction in Leydig cell function is associated with lower semen quality variables: a study of 8182 European young men. Hum. Reprod. 2016; 31: 947-957.

18 Paasch U. The Future of Fractional Lasers. Facial. Plast. Surg. 2016; 32: 261-268.

19 Riammer S, Garten A, Schaab M et al. Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage. Andrology. 2016.

20 Richter D, Geue K, Sender A et al. Medical consultations about fertility preservation with haematological patients of childbearing age: A qualitative study. Eur. J. Oncol. Nurs. 2016; 21: 146-152.

21 Taudorf EH, Lerche CM, Erlendsson AM et al. Fractional laser-assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate. Lasers Surg. Med. 2016; 48: 519-529.

22 Thaysen-Petersen D, Erlendsson AM, Nash JF et al. Side effects from intense pulsed light: Importance of skin pigmentation, fluence level and ultraviolet radiation-A randomized controlled trial. Lasers Surg. Med. 2016.

Forschungsunterstützung

Laufende Forschungsunterstützung (Auswahl)

  • Treatment of pathogens important in diseases of skin and its appendages using laser light 2010-
  • Studies on laser-mediated uptake of systemic drugs – prospects for new dermatological treatments 2011-
  • Early laser treatment investigations to prevent scarring 2012-
  • Laser-assisted drug delivery focusing on anti-cancer treatment of skin tumors 2013-

 

Abgeschlossene Forschungsunterstützung (Auswahl)

  • Comparison of 808 and 980nm linear scanned laser efficacy to remove hair        (EpiCompare)    2011-2012
  • Efficacy of laser hair removal with linear scanned devices at high and low pulses     (EpiConLow)    2009-2011
  • Laser hair removal with sequentially- and linear scanned devices at high fluencies     (EpiCon)    2007-2009
  • Efficacy of fractional erbium:YAG and CO2-Laser for skin resurfacing             (ClinFrax)    2009-2010
  • Investigation of wound healing in response to fractional phothothermolysis         (HealFrax)    2007-2008
  • Influence of laser parameters on histological fractional ablation pattern         (ShootFrax)    2007-2008
  • Human skin explant model to study molecular changes of fractional lasers         (ExplantFrax)    2007-2008
  • Influence of punch ablation by erbium laser on cutaneous remodeling            (PAXEL)    2006-2007

 

Klinische Versuche

“Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or vitamin D analoga.”

Role: Investigator    2005-2007

WaveLight Inc Germany    University of Leipzig    

The main objective is to investigate relapse free intervals after treatment of psoriasis with additional 308 nm laser light.        

 

“Indocyanine Green-augmented diode laser therapy of capillary and venous vascular malformations.”        

Role: Investigator    2010-2013

IIT    University of Leipzig

The main objective is to gain further experience the efficacy of ICG-mediated laser therapy for the treatment of cutaneous capillary vascular malformations which prove to be safe and effective in a pilot study (Study Code ICG-REG_01, EudraCT Nr. 2009-009956-20).        

 

Patente
Winsperm™ Patent 4/2002, 2010 (39945499.7/42)